SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?


To: sjemmeri who wrote (4545)1/4/2006 9:12:34 AM
From: sjemmeriRespond to of 4974
 
12/29/2005 VNDA
Drug developer Vanda Pharmaceuticals files to go public
Vanda Pharmaceuticals, a biopharmaceutical company developing treatments for central nervous system disorders, such as schizophrenia, bipolar disorder, insomnia and depression, filed to go public on Thursday. The Rockville, MD based company has selected JP Morgan, Banc of America Securities and Thomas Weisel Partners to underwrite the deal. Terms and timing have yet to be determined.